Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio Combined With Anemia in Patients With ST-Segment Elevation Myocardial Infarction: A Nationwide Prospective Cohort Study
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective: Data pertaining to the prognostic value of the combination of high neutrophil-to-lymphocyte ratio (NLR) and anemia on admission in patients with ST-segment elevation myocardial infarction (STEMI) are limited. The objective of this study was to investigate the clinical value of baseline NLR in combination with anemia in predicting clinical outcomes after STEMI. Methods: A total of 5,194 consecutive patients with STEMI within 12 hours of symptom onset from the Korea Acute Myocardial Infarction Registry-National Institute of Health database between 2011 and 2015 were categorized into 4 groups according to their NLR and hemoglobin levels: low NLR (<4) without anemia (n=2,722; reference group); high NLR (≥4) without anemia (n=1,527); low NLR with anemia (n=508); and high NLR with anemia (n=437). The co-primary outcomes were 180-day and 3-year all-cause mortality. Results: Mortality rates significantly increased at the 3-year follow-up across the groups (3.3% vs. 5.4% vs. 16.5% vs. 21.7% for 180-day mortality and 5.3% vs. 9.0% vs. 23.8% vs. 33.4% for 3-year mortality; all p-trends <0.001). After adjusting for baseline covariates, the combination of high NLR and anemia was a significant predictor of 180-day mortality after STEMI with low NLR and no anemia as the reference (adjusted hazard ratio, 2.16; 95% confidence interval, 1.58-2.95; p<0.001). Similar findings were observed for the 3-year mortality. Conclusions: This nationwide prospective cohort study showed that the combination of high NLR (≥4) and anemia is a strong predictor of all-cause mortality after STEMI.
Abstract
Objective: Data pertaining to the prognostic value of the combination of high neutrophil-to-lymphocyte ratio (NLR) and anemia on admission in patients with ST-segment elevation myocardial infarction (STEMI) are limited. The objective of this study was to investigate the clinical value of baseline NLR in combination with anemia in predicting clinical outcomes after STEMI. Methods: A total of 5,194 consecutive patients with STEMI within 12 hours of symptom onset from the Korea Acute Myocardial Infarction Registry-National Institute of Health database between 2011 and 2015 were categorized into 4 groups according to their NLR and hemoglobin levels: low NLR (<4) without anemia (n=2,722; reference group); high NLR (≥4) without anemia (n=1,527); low NLR with anemia (n=508); and high NLR with anemia (n=437). The co-primary outcomes were 180-day and 3-year all-cause mortality. Results: Mortality rates significantly increased at the 3-year follow-up across the groups (3.3% vs. 5.4% vs. 16.5% vs. 21.7% for 180-day mortality and 5.3% vs. 9.0% vs. 23.8% vs. 33.4% for 3-year mortality; all p-trends <0.001). After adjusting for baseline covariates, the combination of high NLR and anemia was a significant predictor of 180-day mortality after STEMI with low NLR and no anemia as the reference (adjusted hazard ratio, 2.16; 95% confidence interval, 1.58-2.95; p<0.001). Similar findings were observed for the 3-year mortality. Conclusions: This nationwide prospective cohort study showed that the combination of high NLR (≥4) and anemia is a strong predictor of all-cause mortality after STEMI.
참고문헌 (32)
- O’Gara PT, "2013 ACCF", AHA guideline for the management of ST-elevation myocardial infarction : a report of the American College of Cardiology Foundation, J Am Coll Cardiol, pp.2013, 61[DOI]
- Ibanez B, "2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation : the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)", Eur Heart J, 39, pp.119~177 (2018)
- Daniels MJ, "Reperfusion of ST-segment-elevation myocardial infarction in the COVID-19 era : business as usual?", Circulation, 141, pp.1948~1950 (2020)
- Task Force for the management of COVID-19 of the European Society of Cardiology, "ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up", Eur Heart J, pp.ehab697~ (2021)
- Pan W, "Application of neutrophil", lymphocyte ratio in predicting coronary blood flow and mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention, 2015, pp.66, 9~14
- Dentali F, "Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes : a systematic review and meta-analysis of the literature", Int J Cardiol, 266, pp.31~37 (2018)
- Riley RF, "Guidelines-based treatment of anaemic STEMI patients : practice patterns and effects on in-hospital mortality : a retrospective analysis from the NCDR", Eur Heart J Acute Cardiovasc Care, 2, pp.35~43 (2013)
- Kwok CS, "Meta-analysis of the prognostic impact of anemia in patients undergoing percutaneous coronary intervention", Am J Cardiol, 118, pp.610~620 (2016)
- Cho KH, "Value of early risk stratification using hemoglobin level and neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention", Am J Cardiol, 107, pp.849~856 (2011)
- Kim JH, "Multicenter cohort study of acute myocardial infarction in Korea-interim analysis of the Korea Acute Myocardial Infarction Registry-National Institutes of Health Registry", Circ J, 80, pp.1427~1436 (2016)
- Ross R, "Atherosclerosis--an inflammatory disease", N Engl J Med, 340, pp.115~126 (1999)
- Libby P, "Inflammation in atherosclerosis : from pathophysiology to practice", J Am Coll Cardiol, 54, pp.2129~2138 (2009)
- Barron HV, "Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction : a thrombolysis in myocardial infarction 10 substudy", Circulation, 102, pp.2329~2334 (2000)
- Thomas MR, "Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel", Eur Heart J Acute Cardiovasc Care (2019)
- Gisterå A, "The immunology of atherosclerosis", Nat Rev Nephrol, 13, pp.368~380 (2017)
- Onsrud M, "Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity", Scand J Immunol, 13, pp.573~579 (1981)
- Horne BD, "Which white blood cell subtypes predict increased cardiovascular risk?", J Am Coll Cardiol, 45, pp.1638~1643 (2005)
- Arbel Y, "Neutrophil", lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography, 2012, pp.225, 456~460
- Verdoia M, "Neutrophil to lymphocyte ratio and the extent of coronary artery disease : results from a large cohort study", Angiology, 67, pp.75~82 (2016)
- Pilgrim T, "The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents", Circ Cardiovasc Interv, 5, pp.202~210 (2012)
- Niu X, "Risk stratification based on components of the complete blood count in patients with acute coronary syndrome : a classification and regression tree analysis", Sci Rep, 8, pp.2838~ (2018)
- Oh PC, "Addition of routine blood biomarkers to TIMI risk score improves predictive performance of 1-year mortality in patients with ST-segment elevation myocardial infarction", BMC Cardiovasc Disord, 20, pp.486~ (2020)
- Seung Jin Jun,, "Early Valuable Risk Stratification with Hemoglobin Level and Neutrophil to Lymphocyte Ratio in Patients with Non-ST-Elevation Myocardial Infarction Having an Early Invasive Strategy", 지질·동맥경화학회지, 7(1), pp.50~61 (2018), 한국지질동맥경화학회[DOI]
- Morrow DA, "TIMI risk score for ST-elevation myocardial infarction : a convenient, bedside, clinical score for risk assessment at presentation : an intravenous nPA for treatment of infarcting myocardium early II trial substudy", Circulation, 102, pp.2031~2037 (2000)
- Morrow DA, "A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction : an InTIME II substudy", Lancet, 358, pp.1571~1575 (2001)
- De Luca G, "Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty : implications for early discharge", Circulation, 109, pp.2737~2743 (2004)
- Halkin A, "Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction : the CADILLAC risk score", J Am Coll Cardiol, 45, pp.1397~1405 (2005)
- Fox KA, "Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome : prospective multinational observational study(GRACE)", BMJ, 333, pp.1091~ (2006)
- McNamara RL, "Predicting in-hospital mortality in patients with acute myocardial infarction", J Am Coll Cardiol, 68, pp.626~635 (2016)
- InTIME-II Investigators, "Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction", Eur Heart J, 21, pp.2005~2013 (2000)
- Granger CB, "Predictors of hospital mortality in the global registry of acute coronary events", Arch Intern Med, 163, pp.2345~2353 (2003)
- Eagle KA, "A validated prediction model for all forms of acute coronary syndrome : estimating the risk of 6-month postdischarge death in an international registry", JAMA, 291, pp.2727~2733 (2004)